Key result
Definitive treatment options for ischemic cardiomyopathy remain controversial, highlighting the need for effective approaches combining medical therapy, percutaneous interventions, and surgery.
Why the study?
Does coronary artery bypass grafting or percutaneous coronary intervention improve outcomes in patients with ischemic cardiomyopathy?
Does coronary artery bypass grafting or percutaneous coronary intervention improve outcomes in patients with ischemic cardiomyopathy?
This editorial highlights the ongoing controversy and need for effective treatment strategies, including optimal medical therapy, PCI, and CABG, for patients with ischemic cardiomyopathy.
Despite declining age-standardized death rates for ischemic heart disease over the past several decades, the burden of disease remains substantial, contributing to a growing population with ischemic cardiomyopathy (ICM).1 Definitive treatment options for this population have been fraught by controversy and mostly focused on combinations of optimal medical therapies (OMT), percutaneous interventions, and surgical revascularization. With significant implications for survival, quality of life, and health care costs, effective and efficient approaches to dealing with ICM are needed.
No takes yet. Share an insight, caveat, or question.
Gilbert et al. (2025) conducted an editorial in Ischemic cardiomyopathy. Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention vs. Optimal medical therapies was evaluated. Definitive treatment options for ischemic cardiomyopathy remain controversial, highlighting the need for effective approaches combining medical therapy, percutaneous interventions, and surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: